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Abstract
Medical practice is rooted in our dependence on the best available evidence from incremental scientific
experimentation and rigorous clinical trials. Progress toward determining the true worth of ongoing practice or
suggested innovations can be glacially slow when we insist on following the stepwise scientific pathway, and a
prevailing but imperfect paradigm often proves difficult to challenge. Yet most experienced clinicians and clinical
scientists harbor strong thoughts about how care could or should be improved, even if the existing evidence base
is thin or lacking. One of our Future of Critical Care Medicine conference sessions encouraged sharing of novel
ideas, each presented with what the speaker considers a defensible rationale. Our intent was to stimulate insightful
thinking and free interchange, and perhaps to point in new directions toward lines of innovative theory and
improved care of the critically ill. In what follows, a brief background outlines the rationale for each novel and
deliberately provocative unconfirmed idea endorsed by the presenter.
Introduction
With good justification, medicine is generally viewed as
a conservative discipline whose practice changes at a
deliberate pace. To some extent, this caution is rooted
in our dependence on the published results of incre-
mental scientific experimentation and rigorous clinical
trials to determine the worth of ongoing practice and/or
to guide innovation. In many respects, such a careful
approach serves us well. But progress made in this way
can be slow, and a prevailing but imperfect paradigm
often proves difficult to challenge. Yet most experienced
clinicians and clinical scientists harbor strong thoughts
about how care could or should be improved, even if
the existing evidence base is thin or lacking. One of our
Future of Critical Care Medicine (FCCM) conference
sessions encouraged the sharing of such ideas, each pre-
sented with what the speaker considers a defensible (if
unverified) rationale. The intent of this provocative for-
mat was to stimulate thinking and free interchange, and
perhaps to point in new directions toward lines of inno-
vative theory and improved care of the critically ill. Of
the eight presentations, two can be considered to
address ways to improve the current processes of care
delivery, two to refine existing mechanical organ support
methodologies, two to better assess, regulate and time
treatment options, and two to utilize nutritional path-
ways to improve patient response to life-threatening ill-
ness and reduce the risk of chronic critical illness. In
what follows, a brief background outlines the rationale
for each novel and deliberately provocative unconfirmed
idea endorsed by the presenter.
Promote passion and laughter to energize team
spirit and improve performance
Martin Westphal, MD, PhD
Background
Passion and humor not only represent “nice to have” fea-
tures of the caregiving environment, but also important
contributors to performance and positive results.
Respectful cooperation and communication among staff
members of the multidisciplinary team are fundamental
to effective management and good patient outcomes. In
this context, the attending physician (the supervisor)
should provide professional teaching and encourage the
maturation of the residents, interns, and students. In
turn, the residents should express respect for their super-
visors, thereby contributing to a positive feedback loop
and culture. The why, when, and how of decision-making
should be convincingly explained whenever possible. In
settings characterized by lack of mutual respect and
cooperation, complaints abound and work is done simply
because of necessity or the obligations of duty, but not
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from conviction. Team leaders should always target con-
nection among team members and focus their attention
on the common goal of patient recovery (Figure 1). True
team spirit cannot be forced by monetary incentives and/
or threats, but rather by passion and humor created
within and helping to nurture a positive working environ-
ment. That humor and laughter are important not only
for staff members but also for certain patient populations
has been demonstrated in the literature [1,2]. Working as
a team increases satisfaction and performance of team
members. Passion for the subject and humor represent
key features that encourage team spirit.
Idea
Respect, humor, and positive attitudes build the team
spirit that makes highly effective critical care possible.
Target outcome quality indicators in
perioperative intensive care: goal-directed pro-
action trumps the need for re-action
Sibylle Kozek-Langenecker, MD
Background
Much of critical care practice is based upon reaction
to clinical signs and laboratory findings. As a consequence,
the physician is often one step behind the pathological pro-
cess. In perioperative critical care the consequences of this
approach may be avoidable postoperative complications
that delay recovery or impair long-term survival after
major surgery. A newer approach is to institute goal-
directed therapy based on optimized flow parameters.
Improved tissue perfusion by targeting a stroke volume
optimized to flow (with stopping rules) is a promising
modern alternative to conventional pressure-targeted
approaches in this arena. In some recent studies, complica-
tions have been reduced dramatically using colloids and
crystalloids in preference to transfused red blood cells. In
fact, after major surgery the administration of unneeded
hemoglobin has been associated with increases in ventila-
tion time, septicemia, pneumonia, and renal failure, among
other complications. Threshold concentrations of hemo-
globin once thought appropriate now appear to have been
set too high for most patients. Revision of the transfusion
threshold to lower values appears judicious unless such
signs as ST segment elevation, tachycardia, hypotension, or
lactic acidosis prompt an exception to be made.
Idea
Monitoring quality indicators of outcome routinely, with
evaluation by benchmarks and peer reviews, will allow
us to both realize and quantify real-life improvements in
perioperative intensive care. Flow-guided volume ther-
apy is often essential to achieve sustained net clinical
benefit in the perioperative setting.
Limit power delivery as well as airway pressures
to avoid ventilator-associated lung injury
Luciano Gattinoni, MD
Background
Although excessive forces applied to the lung during
mechanical ventilation are known to cause lung damage,
the exact mechanism by which these physical forces cause
injury and therefore the hazard targets and thresholds at
which the clinician should direct attention are less well
understood. Experiments have shown that damage occurs
when tidal volume encroaches upon the total lung capacity
and pressures rise into a dangerous zone. The total lung
capacity of the injured baby lung varies from patient to
patient, and therefore tidal volume represents an insuffi-
cient marker of ventilator-induced lung injury (VILI) risk
when considered alone without knowing the aerated
volume into which it is delivered. In fact, what appears to
hurt the lung structure more closely relates to the energy
load that the tissue sustains [3]. The determining variables
of the delivered energy per unit time (power) are the peak
pressure and excursion of pressure which the tidal volume
generates within the baby lung, the flow rate (how fast the
tidal volume is delivered and pressure builds), and the
respiration frequency, an intuitively important variable to
consider, whatever the characteristics of the individual
tidal cycle might be. According to current understanding
rooted in experimental science, we need to become more
sophisticated in our understanding of the variables to con-
trol and the targets to identify. A key objective of ongoing
work is to determine the power threshold of ventilation
below which ventilation is always innocent and above
which it is always dangerous. The quantification of such a
threshold, an objective with firm biologic plausibility, will
dictate the mandate to apply or withhold artificial extra-
corporeal support.
Idea
Power delivered to the lung, rather than tidal volume or
any specific pressure associated with the tidal volume,
most directly determines the potential for VILI. Identifi-
cation of the numerical threshold for power delivery
Figure 1 Synergy of forces acting with common purpose.
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that separates safety from injury is feasible to identify
for clinical practice.
Outsource organ support: the case for resting the
kidney during critical illness
Ravindra L. Mehta, MD
Background
Critical illness imposes a significant demand on all organ
systems, including the kidney. The underlying disease pro-
cess–for example, sepsis or burns–increases the metabolic
load while the processes of care–for example, fluid resusci-
tation and nutritional support–contribute to salt and
water retention and add a volume stress. In these settings
the kidney has to work harder to meet the demand and
relies on recruiting additional excretory capacity. Unfortu-
nately, the available reserve capacity maybe compromised
due to age, prior kidney disease, therapeutic interventions,
or comorbidities. Furthermore, the kidney may be subject
to impaired autoregulation from medications, cellular
edema, and tubular damage from nephrotoxic agents.
Although resting the kidney in times of increased
demand may seem counterintuitive, it is possible that the
high demands of critical illness can be met equally well
with continuous renal replacement therapy (CRRT) [4],
thereby reducing the workload otherwise imposed on the
kidney [5]. Moreover, the ability to dissociate solute clear-
ance from volume management provides great flexibility in
maintaining solute levels at any concentration without
compromising volume status. Specific targets and goals can
be met with the increased clearance capacity added to the
kidney’s own. To apply CRRT as an adjunctive, rather than
a rescue measure, we will need to establish parameters that
anticipate increased workload on kidney function and
develop quantifiable metrics for monitoring dynamic
changes in the demand and renal functional capacity [6].
Idea
We should consider prophylactic intervention with
CRRT as part and parcel of the strategy to manage ICU
patients at high risk for renal functional compromise.
We can identify these patients based on quantifiable cri-
teria for demand and renal functional capacity. Preemp-
tive CRRT for protecting kidney is a viable strategy that
will need to be tested in prospective clinical trials.
Use probiotics, poop pills, and fecal transplants to
modify the gut microbiome to improve outcome?
Paul Wischmeyer, MD
Background
The microbes which populate the gut are increasingly
recognized to play important roles in the well-being of
healthy adults. Billions of microbes (in varied proportions
for different individuals) are found within the intestine,
and the absorbed products of their activity influence the
health of our patients. Many microbes of importance can-
not be easily cultured, but almost all can be sequenced by
their RNA. Taken together, this “microbiome” has a
diverse genetic makeup with a profusion of genes that
stands ready to improve or impair the host’s physiological
status. Different body habitats are very different from one
another. Predictably, antibiotics strongly influence the
composition of the microbiome. Indeed, the precise
makeup for any individual is influenced by the environ-
ment in which he/she is immersed. Differences in the
microbiome may be responsible for such phenotypic
expressions as obesity versus normal habitus. Although a
portion of that effect relates to the efficiency with which
food is processed in the intestine, signals generated within
the microbiome may be transported into the host, influen-
cing hormonal conditions that prompt satiety or hunger.
Given the potential power and diversity of the microbiome
and our ability to manipulate its composition, it may be
possible to manipulate the microbiome so as to combat
disease and promote healing. The potential for this thera-
peutic approach has been recently exemplified in the elim-
ination of Clostridium difficile intestinal infection by
instillation of a fecal transplant into the colon of a well-
prepared recipient [7]. Probiotics can influence the com-
position of the existing microbiome, often to the advan-
tage of the patient, with recent systematic reviews showing
a >60% reduction in C. difficile diarrhea post probiotic
therapy [8]. Further, multiple trials of probiotics now
demonstrate significant reductions in overall infections,
including ventilator-associated pneumonia in the ICU
[9,10]. The possibility of reconstituting the microbiome by
first eliminating the ineffective bacterial populations and
replacing them with beneficial ones tailored to improve
patient status and combat disease would appear a promis-
ing prospect for the future. Progress has already been
made in defining the microbiomes of health and critical
illness. It remains to be determined which bacteria should
be orally ingested or rectally instilled to target specific
objectives. At this point it is clear that the provision of
intensive care leads to significant loss in diversity of the
gut microbiome and that this narrowing of the spectrum
may be associated with worse outcome [11].
Idea
We should utilize probiotics and “poop” pills and per-
form targeted stool transplants to re-sod the micro-
biome in the ICU to improve outcome.
Optimize feeding of both the intestinal
microbiome and the patient: dual (enteral-
parenteral) nutritional support
Claude Pichard, MD, PhD
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Background
The importance of the gut microbiome to the well-being of
the critically ill patient has been well demonstrated and
described [12]. This microbiota represents an important
and heretofore unrecognized “organ” which exerts great
influence on a number of cellular mechanisms, such as
those related to immunoreactivity, inflammation, energy
homeostasis, etc. The microbiome is massively and nega-
tively influenced during the ICU stay by many factors,
which include antimicrobial treatments, exposure to patho-
genic flora, fasting or poor nutrition and nonphysiologic
sterile feedings, colonic stasis secondary to physical immo-
bilization, and opioid analgesics [13]. The exact conse-
quences of this radical shift in microbial composition are
only now being explored. From all indications, however, it
appears as if the door has been opened to understand the
consequences of our current nutritional practices and of
the potential for microbiome modification as a novel
means by which to promote health and accelerate healing.
While stool transplantation has grabbed medical head-
lines and has been successfully applied outside the ICU
setting in patients with refractory C. difficile colitis,
Crohn’s disease, and severe obesity, it seems unlikely to
be as easily applied to intensive care patients for reasons
closely related to the timing of treatment and to the prac-
tical aspects of doing so in the ICU setting. To leverage
this intriguing concept of microbiome manipulation, the
approach must be modified for these constraints. In the
initial phase of illness the goal is to maintain a diverse
and physiologic mass of beneficial bacteria and yeasts.
This will require administration of a feeding product
which–far from being sterile–is mostly a mixture of
physiologic bacteria and yeasts and their preferred food.
Following that first phase, the goal will be to optimize
this revised gut microbiome. To do so will require highly
modified feedings that are designed primarily to nourish
the microbes and secondarily to provide nutrients for the
host. In such a setting, enteral nutrition aims at feeding
primarily the intestinal microbiome, whereas parenteral
nutrition could be used to provide or supplement the
nutritional needs of the patient-host.
Idea
Administer feedings that generate and promote a salu-
tary intestinal microbiome for the critically ill patient.
Dance in the rain: restrain dysfunctional
responses to stress and promote gradual
accommodation to abnormal physiologic targets
John J. Marini, MD
Background
In its early years, the practice of critical care evolved
from anesthetic approaches and postoperative practices.
The natural inclination was to strive to restore the “nor-
mal” baseline. The high price of achieving and maintain-
ing normality, however, has been to inflict unintended
injury by our treatments, as exemplified by VILI, drug
toxicities, and oversedation. In part for this reason, our
patients have probably survived the acute phase only to
be saddled with chronic critical illness [14].
Health is characterized by gradual transitions and
homeostatic adaptation to a range of stressors, which
can be mechanical, microbial, environmental, or bio-
chemical. Disease is characterized by failure to adapt
appropriately to such stressors [15]. When successful,
the stress response transitions from an acute “exuber-
ant” phase (perhaps with transient overreaction) into a
more chronic phase that precedes recovery. Some data
argue that the body, although very wise in its responses
and adjustments when stresses are modest and sufficient
time is available, cannot successfully confront sudden,
severe, life-threatening challenges. Evolution simply did
not prepare us to do so without assistance. Rather, our
evolved responses to severe and life-threatening stres-
sors might not be designed to save the victim, but rather
to accelerate his or her demise.
An ideal physiological response to a disease such as
acute respiratory distress syndrome (ARDS) would be to
transition from a rescue phase, through a period of stabili-
zation, to graded system reloading and recovery. Whereas
rescuing the patient from an overwhelming insult is clearly
indicated when natural homeostatic mechanisms are initi-
ally destabilized and ineffective, continuing to do so when
no longer needed may prevent the patient from adapting
to disordered physiology. It is known that, given enough
time, the human body is remarkably adaptable during
health. This adaptive potential is the basis of athletic con-
ditioning as well as high-altitude acclimatization [15,16].
Examples of how patients adapt to severe disorders of phy-
siology caused by disease can be found in the outpatient
setting, as many thrive with remarkable impairments of
gas exchange and cardiac function that would disable a
healthy patient suddenly confronted with the same devia-
tions from normal parameters. To encourage such adapta-
tion in the varied settings of critical illness will require us
to first minimize (buffer) the signal that otherwise stimu-
lates an overly exuberant stress response and then to gra-
dually reload the body so as to encourage successful
adaptation (Figure 2). One relatively simple example
might be to gradually reduce the inspired oxygen concen-
tration to simulate altitude acclimatization. Eventually, the
patient and the physician would accept “permissive
hypoxemia”.
Thus, to prevent chronic critical illness we may
require a two-stage approach to intensive care. In the
first “rescue” phase, the excessive native stress response
would have to be restrained by minimizing demand and
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providing near full support. Afterward, gentle transitions
to less intense therapy would take place. Here in this
second “adaptation” phase, intermittent stresses and rest
periods might be linked with ongoing targeted reduc-
tions of vital supports (Figure 2). These would include
acclimatization, not only to hypoxemia but also to venti-
lating pressure, vasopressors, inotropes, upright body
positioning, muscular exertion, etc.
Idea
First, shelter the patient from the sudden “storm” at dis-
ease onset by restraining the initial stimulus and
response to stress. In later days of treatment, condition
the patient to “dance in the rain” by encouraging gra-
dual accommodation to abnormal physiology.
Practice personalized physiological medicine
using handheld microscopy at the bedside
Can Ince, PhD
Background
Many randomized clinical trials in critical care have
been informative about the sampled populations, but
their results tend to leave clinicians wondering about
value, timing, and application of treatments for the indi-
vidual patient. Current concepts of personalized medi-
cine envision molecular sequencing and analysis and/or
the measurement of biomarkers to allow more effective
therapies to be selected for the individual patient.
Although such approaches may yield benefit, it seems
unlikely for the foreseeable future that taking such an
approach can effectively provide ongoing management
guidance for the continuously changing physiological
status of organ function frequently encountered in the
critically ill patient. A more physiological approach
based on deeper understanding of tissue responses
could allow more precise appreciation of the importance
of choosing one fluid over another [17] or more direct
assessment of the adequacy of blood flow and hemoglo-
bin concentration in providing effective oxygen delivery.
At the present time, global markers of perfusion ade-
quacy such as lactate concentration, although helpful,
do not give sufficiently detailed information regarding
the primary object of therapeutic interest–the status of
the cell. Ultimately, a reliable technique for assessing
the physiological status of subcellular structures would
be at hand to help the clinician select appropriate treat-
ment. This information would then allow an integrative
physiological evaluation of hemodynamic coherence
between the different physiological compartments in the
hierarchy of the cardiovascular system from the systemic
circulation down to subcellular organelles in a continu-
ous manner in response to individualized therapy [18].
An alternative approach to genetic testing for accom-
plishing individualized medicine would be to use perso-
nalized physiological medicine to complement the
information from genomics or randomized clinical trials.
For comprehensive insight into the physiological deter-
minants of disease and/or the effectiveness of treatment,
more detailed information is required at the level of the
regional microcirculation. Bedside handheld video
microscopy of well-selected and accessible “bellwether”
tissues may provide essential clinical information in
more sensitive fashion than do conventional systemic
hemodynamic variables. Such detailed information as
leukocyte kinetics, red blood cell sequestration, and
Figure 2 Potential targets for stepwise adaptation to physiologically abnormal values.
Marini et al. Critical Care 2015, 19:S1
http://www.ccforum.com/content/19/S3/S1
Page 5 of 7
even subcellular abnormalities of the endothelial glyco-
calyx have already been demonstrated with these
devices. Improved optics of the latest generation of
instruments [19] may allow the frontier to move from
the detailed observations of the microcirculation to the
function of the individual cell (Figure 3) so as to lay the
foundations for truly personalized critical care medicine.
Idea
Deploy personalized physiological medicine using hand-
held microscopes that provide detailed, real-time func-
tional observations of the microcirculation, cellular, and
subcellular structures. Doing so at the bedside and inte-
grating this information with measures of organ func-
tion and the systemic circulation provide the clinician
with personalized physiological medicine to confidently
apply tailored therapy to meet the true underlying needs
of the critically ill patient.
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